Fed. Circ. Questions How Aventis Cancer Drug Is Inventive
A Federal Circuit panel on Tuesday repeatedly pushed back on claims by Aventis Pharma S.A. that its prostate cancer drug should be patentable because the drug is inventive, questioning how a...To view the full article, register now.
Already a subscriber? Click here to view full article